Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odile Launay

Showing results (211-220 of 305) with videos related to

Pageof 31
Sort By:
Diabetes|September 22, 2012
HLA-B7-restricted islet epitopes are differentially recognized in type 1 diabetic children and adults and form weak peptide-HLA complexesMatthieu Scotto, Georgia Afonso, Thomas Østerbye, et al.
Frontiers in Immunology|March 26, 2019
Booster Vaccination With GVGH <i>Shigella sonnei</i> 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical TrialOdile Launay, Augustin G W Ndiaye, Valentino Conti, et al.
The European Respiratory Journal|August 27, 2021
In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017-2019: an observational studyAlexandre Descamps, Nezha Lenzi, Florence Galtier, et al.
BMC Infectious Diseases|September 18, 2013
Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trialsOdile Launay, Xavier Duval, Serge Fitoussi, et al.
Vaccine|January 8, 2026
Safety and immunogenicity of BNT162b2 vaccine in children with acute leukaemia: results and perspectives of an open-label, two-centre, phase 1/2 trial with dose finding studyFanny Alby-Laurent, Amani Ouedrani, Pierre Jateau, et al.
Therapie|January 2, 2022
Health crisis: What opportunities for clinical drug research?Dominique Deplanque, Stanislas Cviklinski, Marc Bardou, et al.
Plos One|April 25, 2019
"Real life" use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort studyPierre Gantner, Babacar Sylla, Laurence Morand-Joubert, et al.
The Lancet. HIV|September 15, 2025
Safety, tolerability, and immunogenicity of an adult-specific pneumococcal conjugate vaccine, V116, in people living with HIV (STRIDE-7): a two-part, parallel-group, randomised, active comparator-controlled, international, phase 3 trialJayani Pathirana, Moti Ramgopal, Charlotte Martin, et al.
Plos One|November 1, 2018
Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in FranceLaure-Amélie de Monteynard, Sophie Matheron, Sophie Grabar, et al.
Plos One|March 4, 2015
Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in FranceLaure-Amélie de Monteynard, Rosemary Dray-Spira, Pierre de Truchis, et al.
Pageof 31

Showing results (211-220 of 305) with videos related to

Sort By:
Pageof 31
Diabetes|September 22, 2012
HLA-B7-restricted islet epitopes are differentially recognized in type 1 diabetic children and adults and form weak peptide-HLA complexesMatthieu Scotto, Georgia Afonso, Thomas Østerbye, et al.
Frontiers in Immunology|March 26, 2019
Booster Vaccination With GVGH <i>Shigella sonnei</i> 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical TrialOdile Launay, Augustin G W Ndiaye, Valentino Conti, et al.
The European Respiratory Journal|August 27, 2021
In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017-2019: an observational studyAlexandre Descamps, Nezha Lenzi, Florence Galtier, et al.
BMC Infectious Diseases|September 18, 2013
Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trialsOdile Launay, Xavier Duval, Serge Fitoussi, et al.
Vaccine|January 8, 2026
Safety and immunogenicity of BNT162b2 vaccine in children with acute leukaemia: results and perspectives of an open-label, two-centre, phase 1/2 trial with dose finding studyFanny Alby-Laurent, Amani Ouedrani, Pierre Jateau, et al.
Therapie|January 2, 2022
Health crisis: What opportunities for clinical drug research?Dominique Deplanque, Stanislas Cviklinski, Marc Bardou, et al.
Plos One|April 25, 2019
"Real life" use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort studyPierre Gantner, Babacar Sylla, Laurence Morand-Joubert, et al.
The Lancet. HIV|September 15, 2025
Safety, tolerability, and immunogenicity of an adult-specific pneumococcal conjugate vaccine, V116, in people living with HIV (STRIDE-7): a two-part, parallel-group, randomised, active comparator-controlled, international, phase 3 trialJayani Pathirana, Moti Ramgopal, Charlotte Martin, et al.
Plos One|November 1, 2018
Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in FranceLaure-Amélie de Monteynard, Sophie Matheron, Sophie Grabar, et al.
Plos One|March 4, 2015
Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in FranceLaure-Amélie de Monteynard, Rosemary Dray-Spira, Pierre de Truchis, et al.
Pageof 31